Redhill Biopharma
RDHL
HK$17.58
Share price
-7.76%
Change (1 day)
-83.05%
Change (1 year)
Categories
Revenue for Redhill Biopharma (RDHL)
Revenue in 2023 (TTM): HK$0.28 Billion
According to Redhill Biopharma's latest financial reports the company's current revenue (TTM 
) is HK$0.27 Billion. In 2022 the company made a revenue of HK$0.48 Billion a decrease over the revenue in the year 2021 that were of HK$0.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Redhill Biopharma from 2012 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | HK$0.28 B | -41.99% |
| 2022 | HK$0.48 B | -27.79% |
| 2021 | HK$0.66 B | 34.03% |
| 2020 | HK$0.49 B | 918.31% |
| 2019 | HK$48.99 M | -25.16% |
| 2018 | HK$65.46 M | 109.11% |
| 2017 | HK$31.3 M | 3897.2% |
| 2016 | HK$0.78 M | 3268.33% |
| 2015 | HK$0.02 M | -99.96% |
| 2014 | HK$54.4 M | 58365.98% |
| 2013 | HK$0.09 M | -24.97% |
| 2012 | HK$0.12 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | HK$373.01 B | 134,073.57% | 🇫🇷 France |
 | HK$499.06 B | 179,416.02% | 🇺🇸 USA |
 | HK$312.50 B | 112,308.89% | 🇬🇧 UK |
 | HK$4.75 B | 1,608.85% | 🇮🇱 Israel |
 | HK$128.66 B | 46,180.60% | 🇮🇱 Israel |